迈普医学(301033)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

301033 迈普医学

已收盘 07-18 15:00:00

{"stockData":{"symbol":"301033","market":"SZ","secType":"STK","nameCN":"迈普医学","latestPrice":42.06,"timestamp":1721286183000,"preClose":38.91,"halted":0,"volume":1628899,"delay":0,"floatShares":38201500,"shares":66063000,"eps":0.7267,"marketStatus":"已收盘","marketStatusCode":5,"change":3.15,"latestTime":"07-18 15:00:00","open":40.21,"high":43,"low":39.55,"amount":67435400,"amplitude":0.0887,"askPrice":42.09,"askSize":13,"bidPrice":42.06,"bidSize":40,"shortable":0,"etf":0,"ttmEps":0.7267,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721352600000},"adr":0,"adjPreClose":38.91,"symbolType":"stock","openAndCloseTimeList":[[1721266200000,1721273400000],[1721278800000,1721286000000]],"highLimit":42.8,"lowLimit":35.02,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":66062951,"pbRate":3.99,"roa":"--","roe":"2.32%","epsLYR":0.62,"committee":0.4,"marketValue":2779000000,"floatMarketCap":1607000000,"peRate":57.878078,"changeRate":0.081,"turnoverRate":0.0426,"status":0},"requestUrl":"/m/hq/s/301033","defaultTab":"news","newsList":[{"id":"2452748751","title":"7月18日迈普医学涨8.10%，广发核心竞争力混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2452748751","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452748751?lang=zh_cn&edition=full","pubTime":"2024-07-18 16:18","pubTimestamp":1721290716,"startTime":"0","endTime":"0","summary":"证券之星消息，7月18日迈普医学涨8.10%，收盘报42.06元，换手率4.26%，成交量1.63万手，成交额6743.54万元。根据2024基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为广发核心竞争力混合A。广发核心竞争力混合A目前规模为2.67亿元，最新净值0.8816，较上一交易日下跌0.36%，近一年下跌10.02%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071800033029.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"gpt_icon":0},{"id":"2452174369","title":"迈普医学涨8.10%，国元证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2452174369","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452174369?lang=zh_cn&edition=full","pubTime":"2024-07-18 16:18","pubTimestamp":1721290712,"startTime":"0","endTime":"0","summary":"今日迈普医学涨8.10%，收盘报42.06元。2024年4月26日，国元证券研究员马云涛,朱仕平发布了对迈普医学的研报《2023年报及2024一季度报告点评：集采有望加速产品渗透，新产品大放异彩》，该研报对迈普医学给出“买入”评级。维持“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为72.55%。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为天风证券的张雪、杨松。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071800033027.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301033","000728"],"gpt_icon":0},{"id":"2452145135","title":"牙科医疗概念盘中拉升，迈普医学涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452145135","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452145135?lang=zh_cn&edition=full","pubTime":"2024-07-18 09:41","pubTimestamp":1721266866,"startTime":"0","endTime":"0","summary":"07月18日，牙科医疗概念盘中拉升，截至09点41分，牙科医疗概念整体指数上涨0.60%，报599.630点。从个股上来看，该概念的成分股中，迈普医学涨5.06%，通策医疗、奕瑞科技、爱迪特涨幅居前。从资金上来看，截止发稿，牙科医疗概念主力净流入为-2130.35万，其中奕瑞科技受到资金热捧，主力净流入260.27万；拉长时间线来看，该板块近20日主力资金净流入-11.31亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718094106af92dd80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718094106af92dd80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688301","159891","301033"],"gpt_icon":0},{"id":"2452155329","title":"迈普医学：预计2024年1-6月归属净利润盈利2700万元至3300万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452155329","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452155329?lang=zh_cn&edition=full","pubTime":"2024-07-17 20:00","pubTimestamp":1721217637,"startTime":"0","endTime":"0","summary":"证券之星消息，迈普医学发布业绩预告，预计2024年1-6月归属净利润盈利2700万元至3300万元。迈普医学2024年一季报显示，公司主营收入5720.61万元，同比上升28.59%；归母净利润1494.48万元，同比上升91.19%；扣非净利润1207.26万元，同比上升87.05%；负债率17.16%，投资收益85.01万元，财务费用15.81万元，毛利率81.29%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071700040999.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301033"],"gpt_icon":0},{"id":"2452134361","title":"迈普医学最新公告：预计上半年净利同比增长127.05%-177.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452134361","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452134361?lang=zh_cn&edition=full","pubTime":"2024-07-17 18:31","pubTimestamp":1721212260,"startTime":"0","endTime":"0","summary":"迈普医学公告，预计上半年净利2700万元–3300万元，同比增长127.05% - 177.51%。报告期内，公司围绕年初制定的经营目标有序开展工作，随着市场营销力度的加大，公司2024年半年度主营业务收入稳步增长，盈利能力显著提高导致业绩相应增长。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071700038189.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301033","BK0251"],"gpt_icon":0},{"id":"2452713131","title":"迈普医学(301033.SZ)发预增，预计上半年净利润同比增长127.05%-177.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452713131","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452713131?lang=zh_cn&edition=full","pubTime":"2024-07-17 18:28","pubTimestamp":1721212123,"startTime":"0","endTime":"0","summary":"迈普医学(301033.SZ)发布2024年半年度业绩预告，预计上半年归属于上市公...","market":"us","thumbnail":"https://img.zhitongcaijing.com/astock/25.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/25.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1152176.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["301033"],"gpt_icon":0},{"id":"2452754689","title":"迈普医学（301033）7月16日主力资金净买入119.34万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452754689","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452754689?lang=zh_cn&edition=full","pubTime":"2024-07-17 09:21","pubTimestamp":1721179312,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月16日收盘，迈普医学报收于38.92元，下跌1.84%，换手率0.96%，成交量3667.0手，成交额1425.61万元。近5日资金流向一览见下表：迈普医学融资融券信息显示，融资方面，当日融资买入205.54万元，融资偿还47.91万元，融资净买入157.63万元。迈普医学主营业务：致力于结合人工合成材料特性,利用先进制造技术开发高性能植入医疗器械的高新技术企业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071700015277.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301033","BK0251"],"gpt_icon":0},{"id":"2451899356","title":"迈普医学(301033.SZ)授出46.1万股限制性股票 授予价为22.8元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2451899356","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451899356?lang=zh_cn&edition=full","pubTime":"2024-07-16 19:32","pubTimestamp":1721129554,"startTime":"0","endTime":"0","summary":"智通财经APP讯，迈普医学(301033.SZ)公告，公司董事会认为《广州迈普再生医学科技股份有限公司2024年限制性股票激励计划(草案)》规定的授予条件已经成就,同意确定以2024年7月16日为本激励计划首次授予日，向符合条件的28名激励对象授予限制性股票46.10万股，首次授予价格为22.80元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1151712.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301033","BK0251"],"gpt_icon":0},{"id":"2450820085","title":"【机构调研记录】财通基金调研迈普医学","url":"https://stock-news.laohu8.com/highlight/detail?id=2450820085","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450820085?lang=zh_cn&edition=full","pubTime":"2024-07-11 08:02","pubTimestamp":1720656122,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及7月10日披露的机构调研信息，财通基金近期对1家上市公司进行了调研，相关名单如下：1）迈普医学 个股亮点：主要产品包括人工硬脑（脊）膜补片、颅颌面修补产品、可吸收止血纱、可吸收医用胶、口腔可吸收修复膜、定制式矫治器、可吸收功能性创面修复补片、生物3D打印机。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071100011020.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301033","BK0251"],"gpt_icon":0},{"id":"2450867878","title":"【机构调研记录】先锋基金调研迈普医学","url":"https://stock-news.laohu8.com/highlight/detail?id=2450867878","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450867878?lang=zh_cn&edition=full","pubTime":"2024-07-11 08:01","pubTimestamp":1720656078,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及7月10日披露的机构调研信息，先锋基金近期对1家上市公司进行了调研，相关名单如下：1）迈普医学 个股亮点：主要产品包括人工硬脑（脊）膜补片、颅颌面修补产品、可吸收止血纱、可吸收医用胶、口腔可吸收修复膜、定制式矫治器、可吸收功能性创面修复补片、生物3D打印机。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071100010943.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"gpt_icon":0},{"id":"2450896687","title":"迈普医学：7月10日接受机构调研，中信建投、财通基金等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2450896687","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450896687?lang=zh_cn&edition=full","pubTime":"2024-07-10 19:52","pubTimestamp":1720612335,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年7月10日迈普医学发布公告称公司于2024年7月10日接受机构调研，中信建投刘慧彬、财通基金张胤 王靖瑄、华富基金张瑞、中信保诚王昊、先锋基金吴娜、瑞天投资蔡丰亮、汐泰投资朱丹、博时基金肖瑞瑾、华泰柏瑞邹丽晴、玄元投资廖仕超参与。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071000041938.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0276","301033","601066"],"gpt_icon":0},{"id":"2448636634","title":"迈普医学（301033）7月3日主力资金净卖出72.26万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448636634","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448636634?lang=zh_cn&edition=full","pubTime":"2024-07-04 09:19","pubTimestamp":1720055972,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月3日收盘，迈普医学报收于38.2元，下跌4.62%，换手率1.73%，成交量6614.0手，成交额2536.09万元。近5日资金流向一览见下表：迈普医学融资融券信息显示，融资方面，当日融资买入200.79万元，融资偿还81.11万元，融资净买入119.69万元，连续3日净买入累计249.48万元。迈普医学主营业务：致力于结合人工合成材料特性,利用先进制造技术开发高性能植入医疗器械的高新技术企业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070400013359.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"gpt_icon":0},{"id":"2448197378","title":"迈普医学（301033）7月1日主力资金净卖出141.31万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448197378","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448197378?lang=zh_cn&edition=full","pubTime":"2024-07-02 09:14","pubTimestamp":1719882892,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月1日收盘，迈普医学报收于40.74元，上涨4.17%，换手率2.21%，成交量8443.0手，成交额3403.91万元。近5日资金流向一览见下表：迈普医学融资融券信息显示，融资方面，当日融资买入158.55万元，融资偿还86.31万元，融资净买入72.24万元。迈普医学主营业务：致力于结合人工合成材料特性,利用先进制造技术开发高性能植入医疗器械的高新技术企业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070200006462.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301033","BK0251"],"gpt_icon":0},{"id":"2448922120","title":"【机构调研记录】湘财基金调研迈普医学、海泰新光","url":"https://stock-news.laohu8.com/highlight/detail?id=2448922120","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448922120?lang=zh_cn&edition=full","pubTime":"2024-07-02 08:02","pubTimestamp":1719878534,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及7月1日披露的机构调研信息，湘财基金近期对2家上市公司进行了调研，相关名单如下：1）迈普医学 个股亮点：主要产品包括人工硬脑（脊）膜补片、颅颌面修补产品、可吸收止血纱、可吸收医用胶、口腔可吸收修复膜、定制式矫治器、可吸收功能性创面修复补片、生物3D打印机。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070200004171.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688677","301033","BK0251"],"gpt_icon":0},{"id":"2448922128","title":"【机构调研记录】泰信基金调研肇民科技、迈普医学","url":"https://stock-news.laohu8.com/highlight/detail?id=2448922128","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448922128?lang=zh_cn&edition=full","pubTime":"2024-07-02 08:02","pubTimestamp":1719878531,"startTime":"0","endTime":"0","summary":"泰信基金成立于2003年，截至目前，资产管理规模561.49亿元，排名77/204；资产管理规模190.6亿元，排名106/204；管理公募基金数53只，排名91/204；旗下公募基金经理11人，排名100/204。旗下最近一年表现最佳的公募基金产品为泰信周期回报债券，最新单位净值为1.12，近一年增长5.29%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070200004168.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033","BK0220","301000"],"gpt_icon":0},{"id":"2448292217","title":"【机构调研记录】太平基金调研美好医疗、迈普医学等3只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2448292217","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448292217?lang=zh_cn&edition=full","pubTime":"2024-07-02 08:01","pubTimestamp":1719878507,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及7月1日披露的机构调研信息，太平基金近期对3家上市公司进行了调研，相关名单如下：1）美好医疗 美好医疗2024年一季报显示，公司主营收入2.82亿元，同比下降23.34%；归母净利润5803.99万元，同比下降46.46%；扣非净利润5571.72万元，同比下降44.38%；负债率9.48%，投资收益52.78万元，财务费用-1305.29万元，毛利率38.29%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070200004138.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301363","BK0251","301033"],"gpt_icon":0},{"id":"2448922171","title":"【机构调研记录】博道基金调研迈普医学","url":"https://stock-news.laohu8.com/highlight/detail?id=2448922171","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448922171?lang=zh_cn&edition=full","pubTime":"2024-07-02 08:01","pubTimestamp":1719878499,"startTime":"0","endTime":"0","summary":"博道基金成立于2017年，截至目前，资产管理规模158.07亿元，排名125/204；资产管理规模158.06亿元，排名110/204；管理公募基金数51只，排名92/204；旗下公募基金经理9人，排名116/204。旗下最近一年表现最佳的公募基金产品为博道和祥多元稳健债券A，最新单位净值为1.01，近一年增长0.2%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070200004126.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"gpt_icon":0},{"id":"2448922177","title":"【机构调研记录】凯石基金调研迈普医学","url":"https://stock-news.laohu8.com/highlight/detail?id=2448922177","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448922177?lang=zh_cn&edition=full","pubTime":"2024-07-02 08:01","pubTimestamp":1719878485,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及7月1日披露的机构调研信息，凯石基金近期对1家上市公司进行了调研，相关名单如下：1）迈普医学 个股亮点：主要产品包括人工硬脑（脊）膜补片、颅颌面修补产品、可吸收止血纱、可吸收医用胶、口腔可吸收修复膜、定制式矫治器、可吸收功能性创面修复补片、生物3D打印机。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070200004102.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"gpt_icon":0},{"id":"2448922932","title":"【机构调研记录】先锋基金调研迈威生物、迈普医学","url":"https://stock-news.laohu8.com/highlight/detail?id=2448922932","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448922932?lang=zh_cn&edition=full","pubTime":"2024-07-02 08:01","pubTimestamp":1719878482,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及7月1日披露的机构调研信息，先锋基金近期对2家上市公司进行了调研，相关名单如下：1）迈威生物 个股亮点：公司9MW2821是公司研发的一款靶向Nectin-4的ADC型创新药。先锋基金成立于2016年，截至目前，资产管理规模29.54亿元，排名163/204；资产管理规模28.9亿元，排名147/204；管理公募基金数17只，排名138/204；旗下公募基金经理4人，排名155/204。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407020803009ef04e0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407020803009ef04e0c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","301033","688062","BK0239"],"gpt_icon":0},{"id":"2446575307","title":"中邮证券：给予迈普医学买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2446575307","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446575307?lang=zh_cn&edition=full","pubTime":"2024-06-28 17:10","pubTimestamp":1719565841,"startTime":"0","endTime":"0","summary":"中邮证券有限责任公司蔡明子,陈峻近期对迈普医学进行研究并发布了研究报告《公司发布新版股权激励草案，业绩考核目标更积极》，本报告对迈普医学给出买入评级，当前股价为39.11元。最新盈利预测明细如下：该股最近90天内共有5家机构给出评级，买入评级4家，增持评级1家；过去90天内机构目标均价为51.0。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062800037534.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","301033"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2021-07-26","address":"广东省广州市黄埔区高新技术产业开发区科学城揽月路80号E区第三层","stockEarnings":[{"period":"1week","weight":0.0288},{"period":"1month","weight":0.007},{"period":"3month","weight":0.4001},{"period":"6month","weight":0.0045},{"period":"1year","weight":-0.0369},{"period":"ytd","weight":-0.097}],"companyName":"广州迈普再生医学科技股份有限公司","boardCode":"AI0035","perCapita":"6891股","boardName":"专用设备制造业","registeredCapital":"6606万元","compareEarnings":[{"period":"1week","weight":0.008},{"period":"1month","weight":-0.0176},{"period":"3month","weight":-0.0362},{"period":"6month","weight":0.0461},{"period":"1year","weight":-0.0735},{"period":"ytd","weight":-0.0041}],"survey":"　　广州迈普再生医学科技股份有限公司是一家致力于结合人工合成材料特性，利用先进制造技术开发高性能植入医疗器械的高新技术企业。主要产品包括人工硬脑（脊）膜补片、颅颌面修补产品、可吸收止血纱、可吸收医用胶、口腔可吸收修复膜、定制式矫治器、可吸收功能性创面修复补片、生物 3D打印机。公司在国内率先利用生物增材制造技术开发出用于神经外科手术的可吸收硬脑（脊）膜补片，该产品是入选中国科技部《创新医疗器械产品目录（2018）》的唯一一款脑膜产品、也是目录中仅有的9项“国际原创”产品之一。2023年7月，广东省工业和信息化厅发布第五批国家级专精特新“小巨人”企业公示名单，公司被认定为国家级专精特新“小巨人”企业。","serverTime":1721313067680,"listedPrice":15.14,"stockholders":"5543人(较上一季度减少13.67%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"迈普医学(301033)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供迈普医学(301033)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"迈普医学,301033,迈普医学股票,迈普医学股票老虎,迈普医学股票老虎国际,迈普医学行情,迈普医学股票行情,迈普医学股价,迈普医学股市,迈普医学股票价格,迈普医学股票交易,迈普医学股票购买,迈普医学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"迈普医学(301033)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供迈普医学(301033)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}